Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Response to quality of life after renal denervation

Lambert GW, Hering D, Esler MD, Marusic P, Lambert EA, Tanamas SK, Shaw J, Krum H, Dixon JB, Barton DA, Schlaich MP

(2013), Hypertension, 61(4), e39

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial

Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F

(2013), Eur Heart J, 34(31), 2453-63

Renal nerve ablation reduces augmentation index in patients with resistant hypertension

Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP

(2013), J Hypertens, 31(9), 1893-900

Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure

von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC Jr, Krum H

(2013), Circ Heart Fail, 6(3), 594-605

Clinical benefit of eplerenone in patients with mild symptoms of systolic heart failure already receiving optimal best practice background drug therapy: analysis of the EMPHASIS-HF study

Krum H, Shi H, Pitt B, McMurray J, Swedberg K, van Veldhuisen DJ, Vincent J, Pocock S, Zannad F; EMPHASIS-HF Study Group

(2013), Circ Heart Fail, 6(4), 711-8

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M

(2013), Circulation, 128(2), 132-40

Interaction between baseline and early worsening of renal function and efficacy of renin-angiotensin-aldosterone system blockade in patients with heart failure: insights from the Val-HeFT study

Lesogor A, Cohn JN, Latini R, Tognoni G, Krum H, Massie B, Zalewski A, Kandra A, Hua TA, Gimpelewicz C

(2013), Eur J Heart Fail, 15(11), 1236-44

Safety and efficacy of eplerenone in patients at high risk for hyperkalemia and/or worsening renal function: analyses of the EMPHASIS-HF study subgroups (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure)

Eschalier R, McMurray JJ, Swedberg K, van Veldhuisen DJ, Krum H, Pocock SJ, Shi H, Vincent J, Rossignol P, Zannad F, Pitt B; EMPHASIS-HF Investigators

(2013), J Am Coll Cardiol, 62(17), 1585-93

Renal sympathetic nerve ablation for treatment-resistant hypertension

Krum H, Schlaich M, Sobotka P

(2013), Br J Clin Pharmacol, 76(4), 495-503

Clinical outcomes with synchronized left ventricular pacing: analysis of the adaptive CRT trial

Birnie D, Lemke B, Aonuma K, Krum H, Lee KL, Gasparini M, Starling RC, Milasinovic G, Gorcsan J 3rd, Houmsse M, Abeyratne A, Sambelashvili A, Martin DO

(2013), Heart Rhythm, 10(9), 1368-74

Diuretic use in heart failure and outcomes

von Lueder TG, Atar D, Krum H

(2013), Clin Pharmacol Ther, 94(4), 490-8

The impact of eplerenone at different levels of risk in patients with systolic heart failure and mild symptoms: insight from a novel risk score for prognosis derived from the EMPHASIS-HF trial

Collier TJ, Pocock SJ, McMurray JJ, Zannad F, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, Vincent J, Pitt B

(2013), Eur Heart J, 34(36), 2823-9

New treatment for old disease: management of resistant hypertension by percutaneous renal sympathetic denervation

Kanai T, Krum H

(2013), Rev Esp Cardiol, 66(9), 734-40

Losing ALTITUDE? How should ASTRONAUT launch into ATMOSPHERE

Krum H, Massie B, Abraham WT, Dickstein K, Kober L, McMurray JJ; ATMOSPHERE Investigators

(2013), Eur J Heart Fail, 15(11), 1205-7

Management of heart failure

Krum H, Driscoll A

(2013), Med J Aust, 199(5), 334-9

Cardiac-resynchronization therapy in heart failure with a narrow QRS complex

Ruschitzka F, Abraham WT, Singh JP, Bax JJ, Borer JS, Brugada J, Dickstein K, Ford I, Gorcsan J 3rd, Gras D, Krum H, Sogaard P, Holzmeister J; EchoCRT Study Group

(2013), N Engl J Med, 369(15), 1395-405

The elephant in the room of hypertension treatment: author reply

Campbell DJ, McGrady M, Prior DL, Coller JM, Boffa U, Shiel L, Liew D, Wolfe R, Stewart S, Reid CM, Krum H

(2013), Intern Med J, 43(9), 1052-3

International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension

Schlaich MP, Schmieder RE, Bakris G, Blankestijn PJ, Böhm M, Campese VM, Francis DP, Grassi G, Hering D, Katholi R, Kjeldsen S, Krum H, Mahfoud F, Mancia G, Messerli FH, Narkiewicz K, Parati G, Rocha-Singh KJ, Ruilope LM, Rump LC, Sica DA, Sobotka PA, Tsi

(2013), J Am Coll Cardiol, 62(22), 2031-45

How does renal denervation lower blood pressure and when should this technique be considered for the treatment of hypertension?

Leong KT, Krum H

(2013), Curr Cardiol Rep, 15(11), 414

NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF)

McGrady M, Reid CM, Shiel L, Wolfe R, Boffa U, Liew D, Campbell DJ, Prior D, Stewart S, Krum H

(2013), Int J Cardiol, 169(2), 133-8

558 559 560 561 562